BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC, Moreau R. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One. 2010;5. [PMID: 20957151 DOI: 10.1371/journal.pone.0013160] [Cited by in Crossref: 167] [Cited by in F6Publishing: 188] [Article Influence: 13.9] [Reference Citation Analysis]
Number Citing Articles
1 Sargazi S, Siddiqui B, Qindeel M, Rahdar A, Bilal M, Behzadmehr R, Mirinejad S, Pandey S. Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer. Carbohydrate Polymers 2022;290:119489. [DOI: 10.1016/j.carbpol.2022.119489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
2 Masi L, Capobianco I, Magrì C, Marafini I, Petito V, Scaldaferri F. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. IJMS 2022;23:7991. [DOI: 10.3390/ijms23147991] [Reference Citation Analysis]
3 Yarani R, Shojaeian A, Palasca O, Doncheva NT, Jensen LJ, Gorodkin J, Pociot F. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease. Front Immunol 2022;13:865777. [DOI: 10.3389/fimmu.2022.865777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mohammad Rahimi H, Yadegar A, Asadzadeh Aghdaei H, Mirjalali H, Zali MR. Modulation of microRNAs and claudin-7 in Caco-2 cell line treated with Blastocystis sp., subtype 3 soluble total antigen. BMC Microbiol 2022;22:111. [PMID: 35459091 DOI: 10.1186/s12866-022-02528-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xing J, Liao Y, Zhang H, Zhang W, Zhang Z, Zhang J, Wang D, Tang D. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Front Cell Infect Microbiol 2022;12:804689. [DOI: 10.3389/fcimb.2022.804689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tian Y, Wang TS, Bu H, Shao G, Zhang W, Zhang L. Role of Exosomal miR-223 in Chronic Skeletal Muscle Inflammation. Orthop Surg 2022. [PMID: 35293669 DOI: 10.1111/os.13232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li Q, Zhang H, Dai S. New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease. Front Pediatr 2022;10:714054. [DOI: 10.3389/fped.2022.714054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lian H, Zhong XS, Xiao Y, Sun Z, Shen Y, Zhao K, Ma X, Li Y, Niu Q, Liu M, Powell DW, Liu C, Li Q. Exosomal miR-29b of Gut Origin in Patients With Ulcerative Colitis Suppresses Heart Brain-Derived Neurotrophic Factor. Front Mol Biosci 2022;9:759689. [DOI: 10.3389/fmolb.2022.759689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shen Q, Huang Z, Ma L, Yao J, Luo T, Zhao Y, Xiao Y, Jin Y. Extracellular vesicle miRNAs promote the intestinal microenvironment by interacting with microbes in colitis. Gut Microbes 2022;14:2128604. [PMID: 36176029 DOI: 10.1080/19490976.2022.2128604] [Reference Citation Analysis]
10 Toyonaga T, Saruta M. Role of microRNAs in the Pathophysiology of Ulcerative Colitis. Immuno 2021;1:558-73. [DOI: 10.3390/immuno1040039] [Reference Citation Analysis]
11 Stiegeler S, Mercurio K, Iancu MA, Corr SC. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability. Cells 2021;10:3358. [PMID: 34943865 DOI: 10.3390/cells10123358] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Moret-Tatay I, Cerrillo E, Hervás D, Iborra M, Sáez-González E, Forment J, Tortosa L, Nos P, Gadea J, Beltrán B. Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications. Clin Transl Gastroenterol 2021;12:e00416. [PMID: 34695034 DOI: 10.14309/ctg.0000000000000416] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Zhang Y, Zhang Z, Zhang A. MicroRNA-320a-3p Signatures as a Satisfactory Predictor of Acute Coronary Syndrome and Attenuates Inflammation by Targeting X-Linked Inhibitor of Apoptosis Protein. Artery Res 2021;27:143-50. [DOI: 10.1007/s44200-021-00002-w] [Reference Citation Analysis]
14 Grillo TG, Quaglio AEV, Beraldo RF, Lima TB, Baima JP, Di Stasi LC, Sassaki LY. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World J Gastrointest Oncol 2021; 13(9): 995-1016 [PMID: 34616508 DOI: 10.4251/wjgo.v13.i9.995] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Jabandziev P, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:985-93. [PMID: 32009179 DOI: 10.1093/ibd/izaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
16 Suri K, Bubier JA, Wiles MV, Shultz LD, Amiji MM, Hosur V. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021;10:2204. [PMID: 34571853 DOI: 10.3390/cells10092204] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
17 Alamdari-Palangi V, Vahedi F, Shabaninejad Z, Dokeneheifard S, Movehedpour A, Taheri-Anganeh M, Savardashtaki A. microRNA in inflammatory bowel disease at a glance. Eur J Gastroenterol Hepatol 2021;32:140-8. [PMID: 32558695 DOI: 10.1097/MEG.0000000000001815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yang W, Chen L, Xu L, Bilotta AJ, Yao S, Liu Z, Cong Y. MicroRNA-10a Negatively Regulates CD4+ T Cell IL-10 Production through Suppression of Blimp1. J Immunol 2021;207:985-95. [PMID: 34301843 DOI: 10.4049/jimmunol.2100017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Nardone OM, Shivaji UN, Ferruzza V, Ghosh S, Iacucci M. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring. Inflamm Bowel Dis 2020;26:961-9. [PMID: 31587036 DOI: 10.1093/ibd/izz226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
20 Bastami M, Masotti A, Saadatian Z, Daraei A, Farjam M, Ghanbariasad A, Vahed SZ, Eyvazi S, Mansoori Y, Nariman-Saleh-Fam Z. Critical roles of microRNA-196 in normal physiology and non-malignant diseases: Diagnostic and therapeutic implications. Exp Mol Pathol 2021;122:104664. [PMID: 34166682 DOI: 10.1016/j.yexmp.2021.104664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Jung H, Kim JS, Lee KH, Tizaoui K, Terrazzino S, Cargnin S, Smith L, Koyanagi A, Jacob L, Li H, Hong SH, Yon DK, Lee SW, Kim MS, Wasuwanich P, Karnsakul W, Shin JI, Kronbichler A. Roles of microRNAs in inflammatory bowel disease. Int J Biol Sci 2021;17:2112-23. [PMID: 34131410 DOI: 10.7150/ijbs.59904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Crossland RE, Norden J, Ghimire S, Juric MK, Pearce KF, Lendrem C, Collin M, Mischak-Weissinger E, Holler E, Greinix HT, Dickinson AM. Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease. Front Immunol 2021;12:639171. [PMID: 33790910 DOI: 10.3389/fimmu.2021.639171] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Zhang W, Fu X, Xie J, Pan H, Han W, Huang W. miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways. Mol Ther Nucleic Acids 2021;24:264-73. [PMID: 33815939 DOI: 10.1016/j.omtn.2021.02.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Felwick RK, Dingley GJR, Martinez-Nunez R, Sanchez-Elsner T, Cummings JRF, Collins JE. MicroRNA23a Overexpression in Crohn's Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier. J Crohns Colitis 2020;14:381-92. [PMID: 31626694 DOI: 10.1093/ecco-jcc/jjz145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang J, Wang C, Guo Z, Da B, Zhu W, Li Q. miR-223 improves intestinal inflammation through inhibiting the IL-6/STAT3 signaling pathway in dextran sodium sulfate-induced experimental colitis. Immun Inflamm Dis 2021;9:319-27. [PMID: 33332758 DOI: 10.1002/iid3.395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kempinska-Podhorodecka A, Blatkiewicz M, Wunsch E, Krupa L, Gutkowski K, Milkiewicz P, Milkiewicz M. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis. Clin Transl Gastroenterol 2020;11:e00112. [PMID: 31972611 DOI: 10.14309/ctg.0000000000000112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Long J, He Q, Yin Y, Lei X, Li Z, Zhu W. The effect of miRNA and autophagy on colorectal cancer. Cell Prolif 2020;53:e12900. [PMID: 32914514 DOI: 10.1111/cpr.12900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
28 Costa MO, Harding JCS. Swine dysentery disease mechanism: Brachyspira hampsonii impairs the colonic immune and epithelial repair responses to induce lesions. Microb Pathog 2020;148:104470. [PMID: 32889046 DOI: 10.1016/j.micpath.2020.104470] [Reference Citation Analysis]
29 Mortazavi-Jahromi SS, Aslani M, Mirshafiey A. A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunol Lett 2020;227:8-27. [PMID: 32810557 DOI: 10.1016/j.imlet.2020.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
30 Batra SK, Heier CR, Diaz-Calderon L, Tully CB, Fiorillo AA, van den Anker J, Conklin LS. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1597-606. [PMID: 32793975 DOI: 10.1093/ibd/izaa209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
31 Yao J, Gao RY, Luo MH, Wei C, Wu BH, Guo LL, Wang LS, Wang JY, Li DF. Possible role of microRNA miRNA-IL-25 interaction in mice with ulcerative colitis. Bioengineered 2020;11:862-71. [PMID: 32779953 DOI: 10.1080/21655979.2020.1804176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Liu Y, Zhu F, Li H, Fan H, Wu H, Dong Y, Chu S, Tan C, Wang Q, He H, Gao F, Leng X, Zhou Q, Zhu X. MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis. Aging (Albany NY) 2020;12:14966-77. [PMID: 32713852 DOI: 10.18632/aging.103555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
33 Guz M, Dworzański T, Jeleniewicz W, Cybulski M, Kozicka J, Stepulak A, Celiński K. Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients. Biomed Res Int 2020;2020:4250329. [PMID: 32775420 DOI: 10.1155/2020/4250329] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
34 Rotelli MT, Refolo MG, Lippolis C, Cavallini A, Picciariello A, Piscitelli D, Altomare DF. The role of miRNA-133b and its target gene SIRT1 in FAP-derived desmoid tumor. Oncotarget 2020;11:2484-92. [PMID: 32655835 DOI: 10.18632/oncotarget.27622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Chervy M, Barnich N, Denizot J. Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn's Disease. Int J Mol Sci 2020;21:E3734. [PMID: 32466328 DOI: 10.3390/ijms21103734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
36 Cordeiro B, Jeon P, Boukhaled GM, Corrado M, Lapohos O, Roy DG, Williams K, Jones RG, Gruenheid S, Sagan SM, Krawczyk CM. MicroRNA-9 Fine-Tunes Dendritic Cell Function by Suppressing Negative Regulators in a Cell-Type-Specific Manner. Cell Rep 2020;31:107585. [PMID: 32375032 DOI: 10.1016/j.celrep.2020.107585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Pishgahi A, Abolhasan R, Danaii S, Amanifar B, Soltani-zangbar MS, Zamani M, Kamrani A, Ghorbani F, Mehdizadeh A, Kafil HS, Jadidi-niaragh F, Yousefi B, Hajialiloo M, Yousefi M. Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome. Cytokine 2020;128:155002. [DOI: 10.1016/j.cyto.2020.155002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
38 Mohammadi A, Kelly OB, Smith MI, Kabakchiev B, Silverberg MS. Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects. J Crohns Colitis 2019;13:1459-69. [PMID: 31001642 DOI: 10.1093/ecco-jcc/jjz076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
39 Konstantinidis AΟ, Pardali D, Adamama-Moraitou KK, Gazouli M, Dovas CI, Legaki E, Brellou GD, Savvas I, Jergens AE, Rallis TS, Allenspach K. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 2020;16:69. [PMID: 32087719 DOI: 10.1186/s12917-020-02287-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
40 Wohnhaas CT, Schmid R, Rolser M, Kaaru E, Langgartner D, Rieber K, Strobel B, Eisele C, Wiech F, Jakob I, Gantner F, Herichova I, Vinisko R, Böcher WO, Visvanathan S, Shen F, Panzenbeck M, Raymond E, Reber SO, Delić D, Baum P. Fecal MicroRNAs Show Promise as Noninvasive Crohn's Disease Biomarkers. Crohns Colitis 360 2020;2:otaa003. [PMID: 32551441 DOI: 10.1093/crocol/otaa003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
41 Valmiki S, Ahuja V, Puri N, Paul J. miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway. Front Med (Lausanne) 2019;6:313. [PMID: 32039213 DOI: 10.3389/fmed.2019.00313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
42 Dubois-Camacho K, Diaz-Jimenez D, De la Fuente M, Quera R, Simian D, Martínez M, Landskron G, Olivares-Morales M, Cidlowski JA, Xu X, Gao G, Xie J, Chnaiderman J, Soto-Rifo R, González MJ, Calixto A, Hermoso MA. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis. Front Immunol 2019;10:2449. [PMID: 31824476 DOI: 10.3389/fimmu.2019.02449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
43 Boros É, Nagy I. The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Cells 2019;8:E1461. [PMID: 31752264 DOI: 10.3390/cells8111461] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
44 Hossian AKMN, Mackenzie GG, Mattheolabakis G. miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally? Nanomedicine (Lond) 2019;14:2873-89. [PMID: 31735124 DOI: 10.2217/nnm-2019-0180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
45 Sun J, Liang W, Yang X, Li Q, Zhang G. Cytoprotective effects of galacto-oligosaccharides on colon epithelial cells via up-regulating miR-19b. Life Sciences 2019;231:116589. [DOI: 10.1016/j.lfs.2019.116589] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
46 Feng Y, Zhang Y, Zhou D, Chen G, Li N. MicroRNAs, intestinal inflammatory and tumor.Bioorg Med Chem Lett. 2019;29:2051-2058. [PMID: 31213403 DOI: 10.1016/j.bmcl.2019.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
47 Hagihara Y, Yoshimatsu Y, Mikami Y, Takada Y, Mizuno S, Kanai T. Epigenetic regulation of T helper cells and intestinal pathogenicity. Semin Immunopathol 2019;41:379-99. [DOI: 10.1007/s00281-019-00732-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
48 Chen P, Li Y, Li L, Yu Q, Chao K, Zhou G, Qiu Y, Feng R, Huang S, He Y, Chen B, Chen M, Zeng Z, Zhang S. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease. Aliment Pharmacol Ther 2019;49:733-43. [PMID: 30734320 DOI: 10.1111/apt.15159] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
49 Mohammadi A, Kelly OB, Filice M, Kabakchiev B, Smith MI, Silverberg MS. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease. J Crohns Colitis 2018;12:568-81. [PMID: 29420705 DOI: 10.1093/ecco-jcc/jjy010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
50 Han MK, Baker M, Zhang Y, Yang C, Zhang M, Garg P, Viennois E, Merlin D. Overexpression of CD98 in intestinal epithelium dysregulates miRNAs and their targeted proteins along the ileal villus-crypt axis. Sci Rep 2018;8:16220. [PMID: 30385787 DOI: 10.1038/s41598-018-34474-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Lopetuso LR, De Salvo C, Pastorelli L, Rana N, Senkfor HN, Petito V, Di Martino L, Scaldaferri F, Gasbarrini A, Cominelli F, Abbott DW, Goodman WA, Pizarro TT. IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair. Proc Natl Acad Sci U S A 2018;115:E9362-70. [PMID: 30224451 DOI: 10.1073/pnas.1803613115] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 13.5] [Reference Citation Analysis]
52 Ojha R, Nandani R, Pandey RK, Mishra A, Prajapati VK. Emerging role of circulating microRNA in the diagnosis of human infectious diseases. J Cell Physiol 2019;234:1030-43. [PMID: 30146762 DOI: 10.1002/jcp.27127] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
53 Fukata T, Mizushima T, Nishimura J, Okuzaki D, Wu X, Hirose H, Yokoyama Y, Kubota Y, Nagata K, Tsujimura N, Inoue A, Miyoshi N, Haraguchi N, Takahashi H, Hata T, Matsuda C, Kayama H, Takeda K, Doki Y, Mori M, Yamamoto H. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis. Mol Ther Nucleic Acids 2018;12:658-71. [PMID: 30092402 DOI: 10.1016/j.omtn.2018.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
54 Martin-Alonso A, Cohen A, Quispe-Ricalde MA, Foronda P, Benito A, Berzosa P, Valladares B, Grau GE. Differentially expressed microRNAs in experimental cerebral malaria and their involvement in endocytosis, adherens junctions, FoxO and TGF-β signalling pathways. Sci Rep 2018;8:11277. [PMID: 30050092 DOI: 10.1038/s41598-018-29721-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
55 Omidbakhsh A, Saeedi M, Khoshnia M, Marjani A, Hakimi S. Micro-RNAs -106a and -362-3p in Peripheral Blood of Inflammatory Bowel Disease Patients. Open Biochem J 2018;12:78-86. [PMID: 30069249 DOI: 10.2174/1874091X01812010078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
56 Fiorillo AA, Tully CB, Damsker JM, Nagaraju K, Hoffman EP, Heier CR. Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone. Physiol Genomics 2018;50:735-45. [PMID: 29883261 DOI: 10.1152/physiolgenomics.00134.2017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
57 Pei XF, Cao LL, Huang F, Qiao X, Yu J, Ye H, Xi CL, Zhou QC, Zhang GF, Gong ZL. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease. Pathol Res Pract 2018;214:1095-104. [PMID: 29880327 DOI: 10.1016/j.prp.2018.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
58 Latini A, Ciccacci C, Novelli G, Borgiani P. Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility. Immunol Res 2017;65:811-27. [PMID: 28741258 DOI: 10.1007/s12026-017-8937-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
59 Schönauen K, Le N, von Arnim U, Schulz C, Malfertheiner P, Link A. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2018;24:1547-57. [DOI: 10.1093/ibd/izy046] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 16.0] [Reference Citation Analysis]
60 Viennois E, Pujada A, Zen J, Merlin D. Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease. Compr Physiol 2018;8:731-60. [PMID: 29687900 DOI: 10.1002/cphy.c170032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
61 Ghadiri N, Emamnia N, Ganjalikhani-Hakemi M, Ghaedi K, Etemadifar M, Salehi M, Shirzad H, Nasr-Esfahani MH. Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients. Gene 2018;659:109-17. [PMID: 29551498 DOI: 10.1016/j.gene.2018.03.035] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
62 Wu LY, Ma XP, Shi Y, Bao CH, Jin XM, Lu Y, Zhao JM, Zhou CL, Chen D, Liu HR. Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease. J Gastroenterol Hepatol 2017;32:1706-15. [PMID: 28261881 DOI: 10.1111/jgh.13778] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
63 ElSharawy A, Röder C, Becker T, Habermann JK, Schreiber S, Rosenstiel P, Kalthoff H. Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations. Oncotarget 2016;7:75353-65. [PMID: 27683108 DOI: 10.18632/oncotarget.12205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
64 Oikonomopoulos A, Polytarchou C, Joshi S, Hommes DW, Iliopoulos D. Identification of Circulating MicroRNA Signatures in Crohn's Disease Using the Nanostring nCounter Technology. Inflamm Bowel Dis 2016;22:2063-9. [PMID: 27542126 DOI: 10.1097/MIB.0000000000000883] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
65 Gwiggner M, Martinez-Nunez RT, Whiteoak SR, Bondanese VP, Claridge A, Collins JE, Cummings JRF, Sanchez-Elsner T. MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1. Genes (Basel) 2018;9:E85. [PMID: 29438285 DOI: 10.3390/genes9020085] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
66 Bui TM, Mascarenhas LA, Sumagin R. Extracellular vesicles regulate immune responses and cellular function in intestinal inflammation and repair. Tissue Barriers 2018;6:e1431038. [PMID: 29424657 DOI: 10.1080/21688370.2018.1431038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
67 Ando Y, Mazzurana L, Forkel M, Okazaki K, Aoi M, Schmidt PT, Mjösberg J, Bresso F. Downregulation of MicroRNA-21 in Colonic CD3+ T Cells in UC Remission. Inflamm Bowel Dis 2016;22:2788-93. [PMID: 27824649 DOI: 10.1097/MIB.0000000000000969] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
68 Barnes EL, Burakoff R. New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes. Inflamm Bowel Dis 2016;22:2956-65. [PMID: 27763951 DOI: 10.1097/MIB.0000000000000903] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
69 Schaefer JS. MicroRNAs: how many in inflammatory bowel disease? Curr Opin Gastroenterol. 2016;32:258-266. [PMID: 27138057 DOI: 10.1097/mog.0000000000000284] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
70 Ciccacci C, Politi C, Biancone L, Latini A, Novelli G, Calabrese E, Borgiani P. Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases. Mol Diagn Ther. 2017;21:107-114. [PMID: 27718165 DOI: 10.1007/s40291-016-0240-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
71 Stylianou E. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics. Mol Diagn Ther 2018;22:11-23. [DOI: 10.1007/s40291-017-0298-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
72 Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Olivares M, Rodríguez-Cabezas ME, Gálvez J. Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr Food Res 2017;61. [PMID: 28752563 DOI: 10.1002/mnfr.201700144] [Cited by in Crossref: 57] [Cited by in F6Publishing: 81] [Article Influence: 11.4] [Reference Citation Analysis]
73 Valmiki S, Ahuja V, Paul J. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. World J Gastroenterol 2017; 23(29): 5324-5332 [PMID: 28839432 DOI: 10.3748/wjg.v23.i29.5324] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
74 Palmieri O, Creanza TM, Bossa F, Latiano T, Corritore G, Palumbo O, Martino G, Biscaglia G, Scimeca D, Carella M, Ancona N, Andriulli A, Latiano A. Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling. Int J Mol Sci 2017;18:E1580. [PMID: 28726756 DOI: 10.3390/ijms18071580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
75 Riazalhosseini B, Mohamed R, Apalasamy YD, Langmia IM, Mohamed Z. Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B. Rev Soc Bras Med Trop 2017;50:161-6. [PMID: 28562750 DOI: 10.1590/0037-8682-0416-2016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
76 López-Urrutia E, Coronel-Hernández J, García-Castillo V, Contreras-Romero C, Martínez-Gutierrez A, Estrada-Galicia D, Terrazas LI, López-Camarillo C, Maldonado-Martínez H, Jacobo-Herrera N, Pérez-Plasencia C. MiR-26a downregulates retinoblastoma in colorectal cancer. Tumour Biol 2017;39:1010428317695945. [PMID: 28443472 DOI: 10.1177/1010428317695945] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
77 Guo J, Sun M, Teng X, Xu L. MicroRNA‑7‑5p regulates the expression of TFF3 in inflammatory bowel disease. Mol Med Rep 2017;16:1200-6. [PMID: 28627600 DOI: 10.3892/mmr.2017.6730] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
78 Viennois E, Zhao Y, Han MK, Xiao B, Zhang M, Prasad M, Wang L, Merlin D. Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans. Sci Rep 2017;7:2520. [PMID: 28566745 DOI: 10.1038/s41598-017-02782-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
79 Norén E, Almer S, Söderman J. Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease. BMC Gastroenterol 2017;17:68. [PMID: 28545409 DOI: 10.1186/s12876-017-0620-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
80 Kim HY, Kwon HY, Ha Thi HT, Lee HJ, Kim GI, Hahm KB, Hong S. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease. J Gastroenterol Hepatol. 2016;31:1727-1735. [PMID: 26878986 DOI: 10.1111/jgh.13321] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
81 Duvoisin G, Lopez RN, Day AS, Lemberg DA, Gearry RB, Leach ST. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators Inflamm 2017;2017:1936315. [PMID: 28522897 DOI: 10.1155/2017/1936315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
82 Cao B, Zhou X, Ma J, Zhou W, Yang W, Fan D, Hong L. Role of MiRNAs in Inflammatory Bowel Disease. Dig Dis Sci. 2017;62:1426-1438. [PMID: 28391412 DOI: 10.1007/s10620-017-4567-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
83 Zhou H, Wu L. The development and function of dendritic cell populations and their regulation by miRNAs. Protein Cell 2017;8:501-13. [PMID: 28364278 DOI: 10.1007/s13238-017-0398-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
84 Gabbani T, Deiana S, Marocchi M, Annese V. Genetic risk variants as therapeutic targets for Crohn's disease. Expert Opin Ther Targets 2017;21:381-90. [PMID: 28281904 DOI: 10.1080/14728222.2017.1296431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
85 Kim H, Banerjee N, Sirven MA, Minamoto Y, Markel ME, Suchodolski JS, Talcott ST, Mertens-Talcott SU. Pomegranate polyphenolics reduce inflammation and ulceration in intestinal colitis-involvement of the miR-145/p70S6K1/HIF1α axis in vivo and in vitro. J Nutr Biochem 2017;43:107-15. [PMID: 28282584 DOI: 10.1016/j.jnutbio.2017.02.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
86 Chen Y, Salem M, Boyd M, Bornholdt J, Li Y, Coskun M, Seidelin JB, Sandelin A, Nielsen OH. Relation between NOD2 genotype and changes in innate signaling in Crohn's disease on mRNA and miRNA levels. NPJ Genom Med 2017;2:3. [PMID: 29263823 DOI: 10.1038/s41525-016-0001-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
87 Huang Y, Ma Z, Cui YH, Dong HS, Zhao JM, Dou CZ, Liu HR, Li J, Wu HG. Effects of Herb-Partitioned Moxibustion on the miRNA Expression Profiles in Colon from Rats with DSS-Induced Ulcerative Colitis. Evid Based Complement Alternat Med 2017;2017:1767301. [PMID: 28246536 DOI: 10.1155/2017/1767301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
88 Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2017;49:378-87. [PMID: 28077249 DOI: 10.1016/j.dld.2016.12.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
89 Shi T, Xie Y, Fu Y, Zhou Q, Ma Z, Ma J, Huang Z, Zhang J, Chen J. The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. Mucosal Immunol 2017;10:983-95. [PMID: 27901018 DOI: 10.1038/mi.2016.102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
90 Béres NJ, Szabó D, Kocsis D, Szűcs D, Kiss Z, Müller KE, Lendvai G, Kiss A, Arató A, Sziksz E, Vannay Á, Szabó AJ, Veres G. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:327-35. [PMID: 26752469 DOI: 10.1097/MIB.0000000000000687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
91 Pierdomenico M, Cesi V, Cucchiara S, Vitali R, Prete E, Costanzo M, Aloi M, Oliva S, Stronati L. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:315-326. [PMID: 26752466 DOI: 10.1097/MIB.0000000000000659] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
92 Cordes F, Brückner M, Lenz P, Veltman K, Glauben R, Siegmund B, Hengst K, Schmidt MA, Cichon C, Bettenworth D. MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis: . Inflammatory Bowel Diseases 2016;22:2341-55. [DOI: 10.1097/mib.0000000000000917] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
93 Guan X, Yi Y, Huang Y, Hu Y, Li X, Wang X, Fan H, Wang G, Wang D. Revealing potential molecular targets bridging colitis and colorectal cancer based on multidimensional integration strategy. Oncotarget 2015;6:37600-12. [PMID: 26461477 DOI: 10.18632/oncotarget.6067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
94 Heier CR, Fiorillo AA, Chaisson E, Gordish-Dressman H, Hathout Y, Damsker JM, Hoffman EP, Conklin LS. Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease. Clin Transl Gastroenterol 2016;7:e192. [PMID: 27628422 DOI: 10.1038/ctg.2016.49] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
95 Guo Z, Gong J, Li Y, Gu L, Cao L, Wang Z, Zhu W, Li J. Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn's Disease. Nutrients 2016;8:E519. [PMID: 27556489 DOI: 10.3390/nu8080519] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
96 Ben-Shachar S, Yanai H, Sherman Horev H, Elad H, Baram L, Issakov O, Tulchinsky H, Pasmanik-Chor M, Shomron N, Dotan I. MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes. PLoS One 2016;11:e0159956. [PMID: 27536783 DOI: 10.1371/journal.pone.0159956] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
97 Zou M, Wang F, Jiang A, Xia A, Kong S, Gong C, Zhu M, Zhou X, Zhu J, Zhu W, Cheng W. MicroRNA-3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip-α, by targeting TRAF3. Helicobacter 2017;22:e12348. [DOI: 10.1111/hel.12348] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
98 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
99 Viennois E, Zhao Y, Merlin D. Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine. Inflamm Bowel Dis. 2015;21:2467-2474. [PMID: 25985250 DOI: 10.1097/mib.0000000000000444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
100 Gabbani T, Deiana S, Annese AL, Lunardi S, Annese V. The genetic burden of inflammatory bowel diseases: implications for the clinic? Expert Rev Gastroenterol Hepatol 2016;10:1109-17. [PMID: 27258545 DOI: 10.1080/17474124.2016.1196131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Tomé-Carneiro J, Crespo MC, Iglesias-Gutierrez E, Martín R, Gil-Zamorano J, Tomas-Zapico C, Burgos-Ramos E, Correa C, Gómez-Coronado D, Lasunción MA, Herrera E, Visioli F, Dávalos A. Hydroxytyrosol supplementation modulates the expression of miRNAs in rodents and in humans. J Nutr Biochem 2016;34:146-55. [PMID: 27322812 DOI: 10.1016/j.jnutbio.2016.05.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
102 Wan J, Xia L, Xu W, Lu N. Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.Int J Mol Sci. 2016;17. [PMID: 27187359 DOI: 10.3390/ijms17050709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
103 Peck BC, Weiser M, Lee SE, Gipson GR, Iyer VB, Sartor RB, Herfarth HH, Long MD, Hansen JJ, Isaacs KL, Trembath DG, Rahbar R, Sadiq TS, Furey TS, Sethupathy P, Sheikh SZ. MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility. Inflamm Bowel Dis 2015;21:2178-87. [PMID: 26164662 DOI: 10.1097/MIB.0000000000000478] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
104 Mansour MA, Sabbah NA, Mansour SA, Ibrahim AM. MicroRNA-199b expression level and coliform count in irritable bowel syndrome. IUBMB Life. 2016;68:335-342. [PMID: 27015896 DOI: 10.1002/iub.1495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
105 Xu XM, Zhang HJ. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World J Gastroenterol 2016; 22(7): 2206-2218 [PMID: 26900285 DOI: 10.3748/wjg.v22.i7.2206] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
106 Lewis A, Nijhuis A, Mehta S, Kumagai T, Feakins R, Lindsay JO, Silver A. Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets. Inflamm Bowel Dis 2015;21:1141-50. [PMID: 25636122 DOI: 10.1097/MIB.0000000000000298] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
107 Benz F, Roy S, Trautwein C, Roderburg C, Luedde T. Circulating MicroRNAs as Biomarkers for Sepsis. Int J Mol Sci 2016;17:E78. [PMID: 26761003 DOI: 10.3390/ijms17010078] [Cited by in Crossref: 104] [Cited by in F6Publishing: 137] [Article Influence: 17.3] [Reference Citation Analysis]
108 Moret-Tatay I, Iborra M, Cerrillo E, Tortosa L, Nos P, Beltrán B. Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel. Oxid Med Cell Longev 2016;2016:2325162. [PMID: 26823944 DOI: 10.1155/2016/2325162] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
109 Lee J, Park EJ, Yuki Y, Ahmad S, Mizuguchi K, Ishii KJ, Shimaoka M, Kiyono H. Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis. Sci Rep 2015;5:18174. [PMID: 26647826 DOI: 10.1038/srep18174] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
110 Liao XJ, Mao WM, Wang Q, Yang GG, Wu WJ, Shao SX. MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome. Biochem Biophys Res Commun. 2016;469:288-293. [PMID: 26631964 DOI: 10.1016/j.bbrc.2015.11.102] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
111 Fisher K, Lin J. MicroRNA in inflammatory bowel disease: Translational research and clinical implication. World J Gastroenterol 2015; 21(43): 12274-12282 [PMID: 26604636 DOI: 10.3748/wjg.v21.i43.12274] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
112 Mora-Buch R, Dotti I, Planell N, Calderón-Gómez E, Jung P, Masamunt MC, Llach J, Ricart E, Batlle E, Panés J, Salas A. Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis. Mucosal Immunol 2016;9:950-9. [PMID: 26530134 DOI: 10.1038/mi.2015.108] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
113 Yamamoto-furusho JK, Fonseca-camarillo G. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:2683-95. [DOI: 10.1097/mib.0000000000000500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
114 Britton LE, Cassidy JP, O'Donovan J, Gordon SV, Markey B. Potential application of emerging diagnostic techniques to the diagnosis of bovine Johne's disease (paratuberculosis). Vet J 2016;209:32-9. [PMID: 26831164 DOI: 10.1016/j.tvjl.2015.10.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
115 Hübenthal M, Hemmrich-Stanisak G, Degenhardt F, Szymczak S, Du Z, Elsharawy A, Keller A, Schreiber S, Franke A. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease. PLoS One. 2015;10:e0140155. [PMID: 26466382 DOI: 10.1371/journal.pone.0140155] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
116 Guo Z, Wu R, Gong J, Zhu W, Li Y, Wang Z, Li N, Li J. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease. J Gastroenterol Hepatol 2015;30:109-16. [PMID: 24910152 DOI: 10.1111/jgh.12644] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
117 Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS. Circulating microRNAs as biomarkers of adult Crohn’s disease: . European Journal of Gastroenterology & Hepatology 2015;27:1038-44. [DOI: 10.1097/meg.0000000000000430] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
118 Honardoost MA, Naghavian R, Ahmadinejad F, Hosseini A, Ghaedi K. Integrative computational mRNA-miRNA interaction analyses of the autoimmune-deregulated miRNAs and well-known Th17 differentiation regulators: An attempt to discover new potential miRNAs involved in Th17 differentiation. Gene 2015;572:153-62. [PMID: 26307197 DOI: 10.1016/j.gene.2015.08.043] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
119 Ng PC, Chan KY, Leung KT, Tam YH, Ma TP, Lam HS, Cheung HM, Lee KH, To KF, Li K. Comparative MiRNA Expressional Profiles and Molecular Networks in Human Small Bowel Tissues of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation. PLoS One 2015;10:e0135737. [PMID: 26274503 DOI: 10.1371/journal.pone.0135737] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
120 Tomankova T, Petrek M, Gallo J, Kriegova E. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases. Scand J Immunol. 2012;75:129-141. [PMID: 21988491 DOI: 10.1111/j.1365-3083.2011.02650.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
121 Law IK, Bakirtzi K, Polytarchou C, Oikonomopoulos A, Hommes D, Iliopoulos D, Pothoulakis C. Neurotensin--regulated miR-133α is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis. Gut 2015;64:1095-104. [PMID: 25112884 DOI: 10.1136/gutjnl-2014-307329] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
122 Huang Z, Ma J, Chen M, Jiang H, Fu Y, Gan J, Dong L, Zhang J, Chen J. Dual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors. Mol Ther 2015;23:1611-21. [PMID: 26073885 DOI: 10.1038/mt.2015.111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
123 Cheng X, Zhang X, Su J, Zhang Y, Zhou W, Zhou J, Wang C, Liang H, Chen X, Shi R, Zen K, Zhang CY, Zhang H. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease. Sci Rep. 2015;5:10397. [PMID: 25997679 DOI: 10.1038/srep10397] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
124 Pathak S, Grillo AR, Scarpa M, Brun P, D’Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol Med. 2015;47:e164. [PMID: 25998827 DOI: 10.1038/emm.2015.21] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
125 Mi S, Zhang J, Zhang W, Huang RS. Circulating microRNAs as biomarkers for inflammatory diseases. Microrna 2013;2:63-71. [PMID: 25019052 DOI: 10.2174/2211536611302010007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
126 Min M, Peng L, Yang Y, Guo M, Wang W, Sun G. MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a. Inflamm Bowel Dis. 2014;20:652-659. [PMID: 24583476 DOI: 10.1097/mib.0000000000000009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 8.1] [Reference Citation Analysis]
127 Wei K, Zhang D, Hong J, Zhang C, Feng X, Huang Y, Liu J, Wu L, Wu H, Ma X. Herb-Partitioned Moxibustion and the miRNAs Related to Crohn's Disease: A Study Based on Rat Models. Evid Based Complement Alternat Med 2015;2015:265238. [PMID: 25810742 DOI: 10.1155/2015/265238] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
128 Law IK, Pothoulakis C. MicroRNA-133α regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis. RNA Dis 2015;2:e472. [PMID: 26005712 DOI: 10.14800/rd.472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
129 Chapman CG, Pekow J. The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol. 2015;8:4-22. [PMID: 25553076 DOI: 10.1177/1756283x14547360] [Cited by in Crossref: 99] [Cited by in F6Publishing: 96] [Article Influence: 14.1] [Reference Citation Analysis]
130 Van der Goten J, Vanhove W, Lemaire K, Van Lommel L, Machiels K, Wollants WJ, De Preter V, De Hertogh G, Ferrante M, Van Assche G. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis. PLoS One. 2014;9:e116117. [PMID: 25546151 DOI: 10.1371/journal.pone.0116117] [Cited by in Crossref: 38] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
131 Singh UP, Murphy AE, Enos RT, Shamran HA, Singh NP, Guan H, Hegde VL, Fan D, Price RL, Taub DD, Mishra MK, Nagarkatti M, Nagarkatti PS. miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses. Immunology. 2014;143:478-489. [PMID: 24891206 DOI: 10.1111/imm.12328] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 8.8] [Reference Citation Analysis]
132 Talapka P, Nagy LI, Pál A, Poles MZ, Berkó A, Bagyánszki M, Puskás LG, Fekete &, Bódi N. Alleviated mucosal and neuronal damage in a rat model of Crohn’s disease. World J Gastroenterol 2014; 20(44): 16690-16697 [PMID: 25469038 DOI: 10.3748/wjg.v20.i44.16690] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
133 Stachurska A, Zorro MM, van der Sijde MR, Withoff S. Small and Long Regulatory RNAs in the Immune System and Immune Diseases. Front Immunol 2014;5:513. [PMID: 25368617 DOI: 10.3389/fimmu.2014.00513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
134 Günaltay S, Nyhlin N, Kumawat AK, Tysk C, Bohr J, Hultgren O, Hörnquist EH. Differential expression of interleukin-1/Toll-like receptor signaling regulators in microscopic and ulcerative colitis. World J Gastroenterol 2014; 20(34): 12249-12259 [PMID: 25232259 DOI: 10.3748/wjg.v20.i34.12249] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
135 Stronati L, Pierdomenico M, Cesi V, Costanzo M, Aloi M, Oliva S, Civitelli F, Cucchiara S. MIR320 family regulates NOD2/CARD15: A new mechanism for controlling inflammation? Digestive and Liver Disease 2014;46:e82. [DOI: 10.1016/j.dld.2014.07.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
136 Chuang AY, Chuang JC, Zhai Z, Wu F, Kwon JH. NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells. Inflamm Bowel Dis. 2014;20:126-135. [PMID: 24297055 DOI: 10.1097/01.mib.0000436954.70596.9b] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
137 Huang Z, Shi T, Zhou Q, Shi S, Zhao R, Shi H, Dong L, Zhang C, Zeng K, Chen J, Zhang J. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease. Gut 2014;63:1247-57. [PMID: 24000293 DOI: 10.1136/gutjnl-2012-304213] [Cited by in Crossref: 97] [Cited by in F6Publishing: 97] [Article Influence: 12.1] [Reference Citation Analysis]
138 Nijhuis A, Biancheri P, Lewis A, Bishop CL, Giuffrida P, Chan C, Feakins R, Poulsom R, Di Sabatino A, Corazza GR. In Crohn’s disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts. Clin Sci (Lond). 2014;127:341-350. [PMID: 24641356 DOI: 10.1042/cs20140048] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
139 Zeng L, Cui J, Wu H, Lu Q. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity 2014;47:419-29. [PMID: 24953646 DOI: 10.3109/08916934.2014.929667] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
140 Qu Z, Li W, Fu B. MicroRNAs in autoimmune diseases. Biomed Res Int 2014;2014:527895. [PMID: 24991561 DOI: 10.1155/2014/527895] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
141 Igaz I, Szőnyi M, Varga P, Topa L. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases]. Orv Hetil 2014;155:487-91. [PMID: 24659741 DOI: 10.1556/OH.2014.29864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
142 Zhang L, Cheng J, Fan XM. MicroRNAs: New therapeutic targets for intestinal barrier dysfunction. World J Gastroenterol 2014; 20(19): 5818-5825 [PMID: 24914342 DOI: 10.3748/wjg.v20.i19.5818] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
143 Fengming Y, Jianbing W. Biomarkers of inflammatory bowel disease. Dis Markers. 2014;2014:710915. [PMID: 24963213 DOI: 10.1155/2014/710915] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
144 Fujioka S, Nakamichi I, Esaki M, Asano K, Matsumoto T, Kitazono T. Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximab: Serum microRNA levels in Crohn's disease. J Gastroenterol Hepatol 2014;29:1207-14. [DOI: 10.1111/jgh.12523] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
145 Sobczak M, Fabisiak A, Murawska N, Wesołowska E, Wierzbicka P, Wlazłowski M, Wójcikowska M, Zatorski H, Zwolińska M, Fichna J. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacol Rep 2014;66:766-75. [PMID: 25149979 DOI: 10.1016/j.pharep.2014.04.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 7.1] [Reference Citation Analysis]
146 Zahm AM, Hand NJ, Tsoucas DM, Le Guen CL, Baldassano RN, Friedman JR. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon. J Crohns Colitis. 2014;8:1108-1117. [PMID: 24613022 DOI: 10.1016/j.crohns.2014.02.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
147 Kosovrasti VY, Lukashev D, Nechev LV, Amiji MM. Novel RNA interference-based therapies for sepsis. Expert Opin Biol Ther 2014;14:419-35. [PMID: 24397825 DOI: 10.1517/14712598.2014.875524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
148 Josse C, Bouznad N, Geurts P, Irrthum A, Huynh-Thu VA, Servais L, Hego A, Delvenne P, Bours V, Oury C. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2014;306:G229-G243. [PMID: 24464560 DOI: 10.1152/ajpgi.00484.2012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
149 Principi M, Giorgio F, Losurdo G, Neve V, Contaldo A, Di Leo A, Ierardi E. Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? World J Gastrointest Pathophysiol 2013; 4(4): 100-107 [PMID: 24244878 DOI: 10.4291/wjgp.v4.i4.100] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
150 Thirion M, Ochiya T. Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses. 2013;5:2690-2703. [PMID: 24212236 DOI: 10.3390/v5112690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
151 Torres J, Danese S, Colombel JF. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 2013;62:1642-52. [PMID: 24104885 DOI: 10.1136/gutjnl-2012-303959] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
152 Nguyen HT, Dalmasso G, Müller S, Carrière J, Seibold F, Darfeuille-Michaud A. Crohn’s disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology. 2014;146:508-519. [PMID: 24148619 DOI: 10.1053/j.gastro.2013.10.021] [Cited by in Crossref: 143] [Cited by in F6Publishing: 149] [Article Influence: 15.9] [Reference Citation Analysis]
153 Lin J, Welker NC, Zhao Z, Li Y, Zhang J, Reuss SA, Zhang X, Lee H, Liu Y, Bronner MP. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. Mod Pathol. 2014;27:602-608. [PMID: 24051693 DOI: 10.1038/modpathol.2013.152] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
154 Yu Q, Zhu S, Zhou R, Yi F, Bing Y, Huang S, Wang Z, Wang C, Xia B. Effects of sinomenine on the expression of microRNA-155 in 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice. PLoS One 2013;8:e73757. [PMID: 24066068 DOI: 10.1371/journal.pone.0073757] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
155 Hutchison J, Cohen Z, Onyeagucha BC, Funk J, Nelson MA. How microRNAs influence both hereditary and inflammatory-mediated colon cancers. Cancer Genet. 2013;206:309-316. [PMID: 24042167 DOI: 10.1016/j.cancergen.2013.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
156 Lu C, Chen J, Xu HG, Zhou X, He Q, Li YL, Jiang G, Shan Y, Xue B, Zhao RX. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology. 2014;146:188-199. [PMID: 24036151 DOI: 10.1053/j.gastro.2013.09.006] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 7.4] [Reference Citation Analysis]
157 Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, Marabita F, Locati M, Spinelli A, Nos P. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol. 2013;173:250-258. [PMID: 23607522 DOI: 10.1111/cei.12104] [Cited by in Crossref: 79] [Cited by in F6Publishing: 89] [Article Influence: 8.8] [Reference Citation Analysis]
158 Papaconstantinou I, Stamatis K, Tzathas C, Vassiliou I, Giokas G, Gazouli M. The role of variations within microRNA in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2013;25:399-403. [PMID: 23466513 DOI: 10.1097/meg.0b013e32835c34ea] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
159 Olaru AV, Yamanaka S, Vazquez C, Mori Y, Cheng Y, Abraham JM, Bayless TM, Harpaz N, Selaru FM, Meltzer SJ. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:471-480. [PMID: 23399735 DOI: 10.1097/mib.0b013e31827e78eb] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
160 Wu R, Li Y, Guo Z, Gong J, Zhu W, Li N, Li J. Triptolide ameliorates ileocolonic anastomosis inflammation in IL-10 deficient mice by mechanism involving suppression of miR-155/SHIP-1 signaling pathway. Mol Immunol 2013;56:340-6. [PMID: 23911388 DOI: 10.1016/j.molimm.2013.05.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
161 Coskun M, Bjerrum JT, Seidelin JB, Troelsen JT, Olsen J, Nielsen OH. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis. World J Gastroenterol 2013; 19(27): 4289-4299 [PMID: 23885139 DOI: 10.3748/wjg.v19.i27.4289] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
162 Haneklaus M, Gerlic M, O’Neill LA, Masters SL. miR-223: infection, inflammation and cancer. J Intern Med. 2013;274:215-226. [PMID: 23772809 DOI: 10.1111/joim.12099] [Cited by in Crossref: 221] [Cited by in F6Publishing: 252] [Article Influence: 24.6] [Reference Citation Analysis]
163 Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145:293-308. [PMID: 23751777 DOI: 10.1053/j.gastro.2013.05.050] [Cited by in Crossref: 179] [Cited by in F6Publishing: 175] [Article Influence: 19.9] [Reference Citation Analysis]
164 Raisch J, Darfeuille-Michaud A, Nguyen HTT. Role of microRNAs in the immune system, inflammation and cancer. World J Gastroenterol 2013; 19(20): 2985-2996 [PMID: 23716978 DOI: 10.3748/wjg.v19.i20.2985] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 113] [Article Influence: 13.0] [Reference Citation Analysis]
165 Gheinani AH, Burkhard FC, Monastyrskaya K. Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome. Cell Mol Life Sci 2013;70:3773-89. [PMID: 23463234 DOI: 10.1007/s00018-013-1275-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
166 Ranjha R, Paul J. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer. Inflamm Res. 2013;62:343-355. [PMID: 23417288 DOI: 10.1007/s00011-013-0600-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
167 Shea-Donohue T, Notari L, Sun R, Zhao A. Mechanisms of smooth muscle responses to inflammation. Neurogastroenterol Motil 2012;24:802-11. [PMID: 22908862 DOI: 10.1111/j.1365-2982.2012.01986.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
168 Hu R, O'Connell RM. MicroRNA control in the development of systemic autoimmunity. Arthritis Res Ther 2013;15:202. [PMID: 23379780 DOI: 10.1186/ar4131] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
169 Svrcek M, El-Murr N, Wanherdrick K, Dumont S, Beaugerie L, Cosnes J, Colombel JF, Tiret E, Fléjou JF, Lesuffleur T. Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases. Carcinogenesis. 2013;34:828-834. [PMID: 23288924 DOI: 10.1093/carcin/bgs408] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
170 Feng X, Wang H, Ye S, Guan J, Tan W, Cheng S, Wei G, Wu W, Wu F, Zhou Y. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One. 2012;7:e52782. [PMID: 23285182 DOI: 10.1371/journal.pone.0052782] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 7.9] [Reference Citation Analysis]
171 Tu J, Xing Y, Guo Y, Tang F, Guo L, Xi T. TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155. International Immunopharmacology 2012;14:353-61. [DOI: 10.1016/j.intimp.2012.08.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
172 Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, Vuga LJ, Weksler B, Benos PV, Gibson KF, McMillan M, Kahn M, Kaminski N. Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol 2012;47:879-87. [PMID: 23043088 DOI: 10.1165/rcmb.2011-0377OC] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 12.8] [Reference Citation Analysis]
173 Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18(34): 4629-4634 [PMID: 23002331 DOI: 10.3748/wjg.v18.i34.4629] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
174 Xiong Q, Xu L. Significance of serum microRNAs in patients with gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(22): 2043-2049 [DOI: 10.11569/wcjd.v20.i22.2043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Lapaquette P, Brest P, Hofman P, Darfeuille-michaud A. Etiology of Crohn’s disease: many roads lead to autophagy. J Mol Med 2012;90:987-96. [DOI: 10.1007/s00109-012-0934-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
176 Næss S, Shiryaev A, Hov JR, Franke A, Karlsen TH. Genetics in primary sclerosing cholangitis. Clin Res Hepatol Gastroenterol. 2012;36:325-333. [PMID: 22554879 DOI: 10.1016/j.clinre.2012.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
177 Clark PM, Dawany N, Dampier W, Byers SW, Pestell RG, Tozeren A. Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflamm Bowel Dis. 2012;18:2315-2333. [PMID: 22488912 DOI: 10.1002/ibd.22958] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
178 Spenlé C, Hussenet T, Lacroute J, Lefebvre O, Kedinger M, Orend G, Simon-assmann P. Dysregulation of laminins in intestinal inflammation. Pathologie Biologie 2012;60:41-7. [DOI: 10.1016/j.patbio.2011.10.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
179 Tang Y, Forsyth CB, Keshavarzian A. New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol 2011;5:615-25. [PMID: 21910579 DOI: 10.1586/egh.11.64] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
180 Fassan M, Croce CM, Rugge M. miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol 2011; 17(48): 5231-5239 [PMID: 22219591 DOI: 10.3748/wjg.v17.i48.5231] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
181 Iborra M, Beltrán B, Nos P. Nuevos conocimientos en genética y enfermedad inflamatoria intestinal. ¿alguna utilidad práctica? Gastroenterología y Hepatología 2011;34:591-8. [DOI: 10.1016/j.gastrohep.2011.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
182 Persoz C, Leleu C, Achard S, Fasseu M, Menotti J, Meneceur P, Momas I, Derouin F, Seta N. Sequential air–liquid exposure of human respiratory cells to chemical and biological pollutants. Toxicology Letters 2011;207:53-9. [DOI: 10.1016/j.toxlet.2011.07.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
183 Actis GC, Rosina F, Mackay IR. Inflammatory bowel disease: beyond the boundaries of the bowel. Expert Rev Gastroenterol Hepatol 2011;5:401-10. [PMID: 21651357 DOI: 10.1586/egh.11.23] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
184 Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, Scholz CC, Simpson DA, Leonard MO, Tambuwala MM, Cummins EP. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol. 2011;31:4087-4096. [PMID: 21807897 DOI: 10.1128/mcb.01276-10] [Cited by in Crossref: 186] [Cited by in F6Publishing: 188] [Article Influence: 16.9] [Reference Citation Analysis]
185 Archanioti P, Gazouli M, Theodoropoulos G, Vaiopoulou A, Nikiteas N. Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis. 2011;5:520-524. [PMID: 22115369 DOI: 10.1016/j.crohns.2011.05.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
186 Tréton X, Pédruzzi E, Cazals-Hatem D, Grodet A, Panis Y, Groyer A, Moreau R, Bouhnik Y, Daniel F, Ogier-Denis E. Altered endoplasmic reticulum stress affects translation in inactive colon tissue from patients with ulcerative colitis. Gastroenterology. 2011;141:1024-1035. [PMID: 21699776 DOI: 10.1053/j.gastro.2011.05.033] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
187 Pekow JR, Dougherty U, Mustafi R, Zhu H, Kocherginsky M, Rubin DT, Hanauer SB, Hart J, Chang EB, Fichera A. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis. 2012;18:94-100. [PMID: 21557394 DOI: 10.1002/ibd.21742] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 8.0] [Reference Citation Analysis]
188 Pekow JR, Kwon JH. MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:187-193. [PMID: 21425211 DOI: 10.1002/ibd.21691] [Cited by in Crossref: 104] [Cited by in F6Publishing: 105] [Article Influence: 9.5] [Reference Citation Analysis]
189 O'neill LA, Sheedy FJ, Mccoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011;11:163-75. [DOI: 10.1038/nri2957] [Cited by in Crossref: 593] [Cited by in F6Publishing: 600] [Article Influence: 53.9] [Reference Citation Analysis]
190 Majd M, Hosseini A, Ghaedi K, Kiani-Esfahani A, Tanhaei S, Shiralian-Esfahani H, Rahnamaee SY, Mowla SJ, Nasr-Esfahani MH. MiR-9-5p and miR-106a-5p dysregulated in CD4+ T-cells of multiple sclerosis patients and targeted essential factors of T helper17/regulatory T-cells differentiation. Iran J Basic Med Sci 2018;21:277-83. [PMID: 29511494 DOI: 10.22038/ijbms.2018.25382.6275] [Cited by in F6Publishing: 6] [Reference Citation Analysis]